Evidence map›Paper›PMID 28723259›Full record

ArticleCell cycle (Georgetown, Tex.)2017

Inappropriate movement of Rac1 contributes to glucotoxicity of the islet β-cell.

Anjaneyulu Kowluru

Abstract readEditorialComment
In one paragraph

Article in Cell cycle (Georgetown, Tex.), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Hyperglycemic Conditions Promote Rac1-Mediated Serine536 Phosphorylation of p65 Subunit of NFκB (RelA) in Pancreatic Beta Cells.Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology · 2022
    Article
  3. Review
  4. Review
  5. [Effects of glycosylated hemoglobin and disease course on islet β-cell function in patients with type 2 diabetes].Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2019
    Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author.

Anjaneyulu Kowlurua β-Cell Biochemistry Laboratory, John D. Dingell VA Medical Center, Department of Pharmaceutical Sciences , Wayne State University , Detroit , MI , USA.ORCID 0000-0003-1700-0077

Funding

Regional Pilot And Feasibility Study Grants ProgramP30DK020572 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Scott Soleimanpour · 2013 to 2026
$24.3M
Novel Regulators of Islet Beta-Cell Function in Health and DiabetesI01BX002801 · VA · JOHN D DINGELL VA MEDICAL CENTER · PI KOWLURU, ANJANEYULU · 2015 to 2018
–
BLRD VA I01 BX002801NIDDK NIH HHS P30 DK020572
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Insulin-Secreting CellsIslets of Langerhans

Identifiers

PMID28723259
PMCPMC5553397

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.